Syno Capital

Profile

Syno Capital is a global healthcare and biotech investment firm based in New York City, founded in 2015. The firm was co-founded by Dr. Justin Xiang, who has a background as a Senior Scientist at Schrodinger Inc., and Joseph Weilgus, who also founded Project Sunshine. The team includes a Chief Investment Officer, an analyst with experience in healthcare and enterprise software startups, and other professionals. Syno Capital distinguishes itself through its emphasis on cross-border collaborations, particularly between the United States and China, and its rigorous, science-driven investment approach.

Syno Capital invests in healthcare innovations, focusing on biotechnology and medical devices. The firm targets investments primarily within the healthtech sector, fostering collaborations globally. It engages in diverse stages from pre-seed to Series B rounds, with a particular interest in breakthrough innovations. Syno Capital operates with affiliated partners such as the New Legacy Group and Inning One, though further specifics about fund structures or limited partnerships are not detailed on their site.

Notable investments made by Syno Capital include various biotech, diagnostic, and healthcare companies in collaboration with co-founders and other companies related to its affiliated partners. The specific portfolio companies are not listed in the available information.